<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: Can Biogen&#8217;s New Incubator Help Fill the Drug Pipeline?</title>
	<atom:link href="http://www.xconomy.com/boston/2007/07/19/can-biogens-new-incubator-help-fill-the-drug-pipeline/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.xconomy.com/boston/2007/07/19/can-biogens-new-incubator-help-fill-the-drug-pipeline/</link>
	<description>Business + Technology in the Exponential Economy</description>
	<lastBuildDate>Sat, 21 Nov 2009 22:30:41 -0600</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.6</generator>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
		<item>
		<title>By: Anonymous Xconomist</title>
		<link>http://www.xconomy.com/boston/2007/07/19/can-biogens-new-incubator-help-fill-the-drug-pipeline/comment-page-1/#comment-164</link>
		<dc:creator>Anonymous Xconomist</dc:creator>
		<pubDate>Fri, 20 Jul 2007 13:21:15 +0000</pubDate>
		<guid isPermaLink="false">http://www.xconomy.com/2007/07/19/can-biogens-new-incubator-help-fill-the-drug-pipeline/#comment-164</guid>
		<description>One additional thought - the apparent flaws in the model could potentially be addressed and it&#039;s nice to at least see that Biogen is thinking outside the box with Rainer Fuchs as a catalyst.</description>
		<content:encoded><![CDATA[<p>One additional thought &#8211; the apparent flaws in the model could potentially be addressed and it&#8217;s nice to at least see that Biogen is thinking outside the box with Rainer Fuchs as a catalyst.</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Anonymous Xconomist</title>
		<link>http://www.xconomy.com/boston/2007/07/19/can-biogens-new-incubator-help-fill-the-drug-pipeline/comment-page-1/#comment-155</link>
		<dc:creator>Anonymous Xconomist</dc:creator>
		<pubDate>Thu, 19 Jul 2007 22:30:20 +0000</pubDate>
		<guid isPermaLink="false">http://www.xconomy.com/2007/07/19/can-biogens-new-incubator-help-fill-the-drug-pipeline/#comment-155</guid>
		<description>This concept is intriguing.  However, it appears to have much of the downside of a licensing deal (closing off future options and limiting other financing routes) yet most of the risk stays with the start-up company/entrepreneur.  For example if something doesn&#039;t move forward to an acquisition by Biogen there could be a taint associated with it. Furthermore, it sounds like one needs to jump through many of the hoops and politics inherent to a big company but doesn&#039;t really have the full commitment of the company. Almost like living with a guy that isn&#039;t sure he wants to marry you...  Better to stay independent if you have other options but maybe a good fit for the girls who can&#039;t get a date?</description>
		<content:encoded><![CDATA[<p>This concept is intriguing.  However, it appears to have much of the downside of a licensing deal (closing off future options and limiting other financing routes) yet most of the risk stays with the start-up company/entrepreneur.  For example if something doesn&#8217;t move forward to an acquisition by Biogen there could be a taint associated with it. Furthermore, it sounds like one needs to jump through many of the hoops and politics inherent to a big company but doesn&#8217;t really have the full commitment of the company. Almost like living with a guy that isn&#8217;t sure he wants to marry you&#8230;  Better to stay independent if you have other options but maybe a good fit for the girls who can&#8217;t get a date?</p>
]]></content:encoded>
	</item>
</channel>
</rss>
